Variant NM_000492.4:c.2491G>T
| Name | NM_000492.4:c.2491G>T |
| Protein name | NP_000483.3:p.(Glu831*) |
| Genomic name (hg19) | chr7:g.117234984G>T UCSC |
| Genomic name (hg38) | chr7:g.117594930G>T UCSC |
| #Exon/intron | exon 15 |
| Legacy Name | E831X |
| Class | disease-causing |
| Subclass | CF-causing |
| WT sequence | TAATAGCCATAATTCTTTTATTCAG G AGTGCTTTTTTGATGATATGGAGAG |
| Mutant sequence | TAATAGCCATAATTCTTTTATTCAG T AGTGCTTTTTTGATGATATGGAGAG |
![]() |
![]() | dbSNP rs397508387 |
![]() Not found | ![]() |
| Modulator | FDA approval | EMA approval | in vitro / ex vivo data | clinical data |
| IVA | yes | no | no | yes |
| TEZ-IVA | yes | no | no | yes |
| ELX-TEZ-IVA | yes | no | yes | no |
clinical and functional data presented above are provided by Vertex
No patient found in CFTR-NGS catalogue |
| TOTAL NUMBER OF PATIENTS | 5 |
|---|---|
| CF | 4 |
| CFTR-RD | 1
|
| Color code: non disease-causing < likely benign < VUS < likely pathogenic < disease-causing |
| Phenotype | Patient ID | Variant status | Additional variants |
|---|---|---|---|
| CRS-NP | 349 | heterozygote | varying clinical consequence - Trans VUS1- Undef |
| CF | 6555 | heterozygote | CF-causing- Undef |
| CF | 5094 | heterozygote | CF-causing - Trans |
| CF | 6177 | heterozygote | CF-causing- Undef |
| CF | 6536 | heterozygote | CF-causing- Undef |
| Color code: non disease-causing < likely benign < VUS < likely pathogenic < disease-causing |
| CFTR variants are clustered into five groups (click here for more details about the classification of variants): |
|